Invited Talk RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- Micromets, Molecular Radiation Biology & Varis/CADPLAN
- MIND THE GAP: Bridging Malaria Laboratory & Field Transmission-Biology Studies
- Minimal Residual Disease (MRD) as a Surrogate Endpoint in Acute Lymphoblastic Leukemia (ALL)
- Minimize Exposure: Correlating Identities Across the Enterprise
- Mining human saliva for pathogen exosome biomarker discovery and the development of novel diagnostics
- Minorities in Medicine Monthly Series
- Misfolded mutant SOD1, Insoluble mutant SOD1, and Inclusions
- Misfolded mutant SOD1, Insoluble mutant SOD1, and Inclusions
- Misfolding and aggregation of mutant SOD1 in ALS
- Misfolding and aggregation of mutant superoxide dismutase 1 in familial ALS
- Misfolding and aggregation of mutant superoxide dismutase 1 in familial ALS
- Misfolding and aggregation of mutant superoxide dismutase 1 in familial ALS
- Misfolding and aggregation of protein in neurodegenerative disease
- Misfolding and aggregation of SOD1 in familial ALS
- Misfolding and aggregation of SOD1 in familial ALS
- Misfolding and aggregation of SOD1 in familial ALS
- Misfolding of SOD1 in familial ALS
- Misfolding of SOD1 in familial ALS
- Mixed Anxiety
- Mobilizing the Institution to Create Successful Informatics Solutions
- MoCA Performance as a function of GABA in the context of aging
- Modeling Alzheimer's disease in transgenic mice
- Modeling and preventing Abeta deposition in AD mouse models
- Modeling Human Neurodegenerative Disease in Transgenic Mice
- Modeling Neurodegenerative disease in transgenic mice
- Modeling Neurodegenerative Disease in Transgenic Mice
- Modeling Neurodegenerative Disease in Transgenic Mice
- Models of Alzheimer's Disease and Huntington's Disease
- Models of y-secretase activity
- Moderate Alcohol and Aging: Real or Imagined Interaction Effects?